ALA ASX Chart
Snapshot
Arovella Therapeutics Limited (ALA, formerly Suda Pharmaceuticals Ltd)is a biotechnology company focused on developing therapies to treat human disease. Arovella's two focus areas are oncology and conditions that impact the central nervous system. Arovella is developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | +51.63% |
Latest Arovella Therapeutics Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Osborne Park WA 6017 |
Website | www.arovella.com |
Registry | Automic |
Auditor | HLB Mann Judd (WA Partnership) |
Date Listed | 24 Jan 2002 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
29/08/2024 | Report (Prelim) |
29/08/2024 | Report (Annual) |
26/02/2025 | Report (Interim) |
Former Company Names
- Suda Pharmaceuticals Ltd (SUD ), 22/10/2021
- Suda Ltd (SUD), 04/12/2017
- Eastland Medical Systems Ltd (EMS), 06/12/2012
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
ALA directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of ALA directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for ALA in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
14-06-23 | Richard John Mann | 54,458,288 | -- | 6.40 |
18-05-23 | Merchant Funds Management Pty Ltd | 8,606,036 | 10.27 | 11.36 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.050 | 30 June |
2022 | $0.023 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.